DK4023651T3 - Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme - Google Patents
Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme Download PDFInfo
- Publication number
- DK4023651T3 DK4023651T3 DK22153273.2T DK22153273T DK4023651T3 DK 4023651 T3 DK4023651 T3 DK 4023651T3 DK 22153273 T DK22153273 T DK 22153273T DK 4023651 T3 DK4023651 T3 DK 4023651T3
- Authority
- DK
- Denmark
- Prior art keywords
- same
- pharmaceutical composition
- optically active
- active pyranochromenylphenol
- derivative
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160081674 | 2016-06-29 | ||
| EP17820539.9A EP3480200B1 (en) | 2016-06-29 | 2017-06-29 | Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4023651T3 true DK4023651T3 (da) | 2023-11-20 |
Family
ID=60787377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22153273.2T DK4023651T3 (da) | 2016-06-29 | 2017-06-29 | Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20190152984A1 (da) |
| EP (2) | EP4023651B1 (da) |
| JP (2) | JP2019520381A (da) |
| KR (1) | KR102388965B1 (da) |
| CN (1) | CN109476676B (da) |
| AU (1) | AU2017287746B2 (da) |
| BR (1) | BR112018077392A2 (da) |
| CA (1) | CA3028954C (da) |
| DK (1) | DK4023651T3 (da) |
| ES (2) | ES2929931T3 (da) |
| IL (1) | IL263826B2 (da) |
| MX (1) | MX2018016361A (da) |
| PL (2) | PL4023651T3 (da) |
| SG (1) | SG11201811796SA (da) |
| TW (1) | TWI731998B (da) |
| WO (1) | WO2018004263A1 (da) |
| ZA (1) | ZA201900121B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180037584A (ko) * | 2016-10-04 | 2018-04-12 | 주식회사 글라세움 | 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법 |
| KR20200105198A (ko) * | 2019-02-28 | 2020-09-07 | 주식회사 글라세움 | 신경계 질환의 예방 또는 치료용 약학적 조성물 |
| KR20220166202A (ko) | 2021-06-08 | 2022-12-16 | 주식회사 글라세움 | 자가면역 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050035142A (ko) * | 2001-10-11 | 2005-04-15 | 카네카 코포레이션 | 페록시좀 증식제 응답성 수용체 리간드제 및 그 제조 방법 |
| TW200513194A (en) * | 2003-07-31 | 2005-04-16 | Kaneka Corp | Fat and oil processed composition for prevention and/or amelioration of life-style related disease |
| WO2007058480A1 (en) * | 2005-11-16 | 2007-05-24 | Md Bioalpha Co., Ltd. | Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin |
| KR102344479B1 (ko) * | 2013-12-24 | 2021-12-29 | 주식회사 글라세움 | 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물 |
| KR101742274B1 (ko) | 2014-12-31 | 2017-06-01 | 주식회사 과학기술분석센타 | 소규모 상수시설 통합 관리 시스템의 수질 측정 장치 |
| KR20180037584A (ko) * | 2016-10-04 | 2018-04-12 | 주식회사 글라세움 | 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법 |
-
2017
- 2017-06-29 SG SG11201811796SA patent/SG11201811796SA/en unknown
- 2017-06-29 JP JP2018569103A patent/JP2019520381A/ja active Pending
- 2017-06-29 EP EP22153273.2A patent/EP4023651B1/en active Active
- 2017-06-29 CN CN201780040744.8A patent/CN109476676B/zh active Active
- 2017-06-29 CA CA3028954A patent/CA3028954C/en active Active
- 2017-06-29 DK DK22153273.2T patent/DK4023651T3/da active
- 2017-06-29 AU AU2017287746A patent/AU2017287746B2/en active Active
- 2017-06-29 ES ES17820539T patent/ES2929931T3/es active Active
- 2017-06-29 TW TW106121811A patent/TWI731998B/zh active
- 2017-06-29 EP EP17820539.9A patent/EP3480200B1/en active Active
- 2017-06-29 US US16/313,777 patent/US20190152984A1/en not_active Abandoned
- 2017-06-29 PL PL22153273.2T patent/PL4023651T3/pl unknown
- 2017-06-29 WO PCT/KR2017/006863 patent/WO2018004263A1/ko unknown
- 2017-06-29 PL PL17820539.9T patent/PL3480200T3/pl unknown
- 2017-06-29 ES ES22153273T patent/ES2964146T3/es active Active
- 2017-06-29 MX MX2018016361A patent/MX2018016361A/es unknown
- 2017-06-29 BR BR112018077392-1A patent/BR112018077392A2/pt active Search and Examination
- 2017-06-29 KR KR1020170082391A patent/KR102388965B1/ko active IP Right Grant
-
2018
- 2018-12-19 IL IL263826A patent/IL263826B2/en unknown
-
2019
- 2019-01-08 ZA ZA2019/00121A patent/ZA201900121B/en unknown
-
2020
- 2020-08-06 JP JP2020133796A patent/JP7036871B2/ja active Active
- 2020-12-08 US US17/114,584 patent/US11332475B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3411358T3 (da) | Substitueret piperidinforbindelse og anvendelse deraf. | |
| DK3328843T3 (da) | 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning | |
| DK3362445T3 (da) | Oxadiazolaminderivatforbindelser som histondeacetylase 6-inhibitor, og den farmaceutiske sammensætning dermed | |
| DK3347472T3 (da) | Sammensætninger som indeholder cyp76ad1- clade polypeptider og anvendelse heraf. | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3297637T3 (da) | Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf | |
| DK3368554T3 (da) | Langtidsvirkende fgf21-fusionsproteiner og farmaceutisk sammensætning omfattende samme | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| DK3330258T3 (da) | 1, 3, 5-triazinderivat og fremgangsmåde til anvendelse af samme | |
| MA50541A (fr) | Formulations pharmaceutiques | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| DK3619201T3 (da) | Herbicidvirksomme 4-difluormethylbenzoylamider | |
| MA46867A (fr) | Formulations pharmaceutiques | |
| DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| DK3554534T3 (da) | Farmaceutisk sammensætning omfattende insulin | |
| DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf | |
| DK3275454T3 (da) | Farmaceutisk sammensætning med silybin, ve og l-carnitin | |
| DK3288825T3 (da) | Teleskopisk adgangsbro, enhed forsynet hermed og tilhørende fremgangsmåde | |
| DK3608334T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formuleringer og anvendelse deraf | |
| DK3464260T3 (da) | Forbindelser, der indeholder ureamotiver, og derivater deraf som antibakterielle lægemidler | |
| DK3383397T3 (da) | Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin | |
| DK3386956T3 (da) | Fumagillolderivater og polymorfer deraf |